and the message board has gone eerily quiet. seems like interest is fading in this one even as the broad market moves to new highs. of course that can change on a dime w/good news, but we basically have no news, ever. the story is taking a long time to unfold, or maybe it just seems that way.
I disagree w/that jmsmttly. there is some significant insider investment in this company that is not momo money. It is the lack of news, the lack of more timely disclosure on unit placement rates, and threat of competing diagnostic alternatives that is weighing on the price IMO. Maybe everyone has just pulled in their horns until the next CC since the last one was a bit disappointing in guiding to the low end of the range on product placements due to European weakness. The company does need to show some accelerated momentum in its product acceptance and some top line revenue very soon, but there is a real product here not just a science project.
convincingly below both 200 day and 50 day MA. had been holding in a very broad $2.85-$3.15 per share price range, but now clearly has broken to the downside. really need some good news and evidence that the cash burn is ameliorating.